Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 312

1.

Altered motor activity, exploration and anxiety in heterozygous neuregulin 1 mutant mice: implications for understanding schizophrenia.

Karl T, Duffy L, Scimone A, Harvey RP, Schofield PR.

Genes Brain Behav. 2007 Oct;6(7):677-87. Epub 2007 Feb 13.

2.

Disruption to social dyadic interactions but not emotional/anxiety-related behaviour in mice with heterozygous 'knockout' of the schizophrenia risk gene neuregulin-1.

O'Tuathaigh CM, O'Connor AM, O'Sullivan GJ, Lai D, Harvey R, Croke DT, Waddington JL.

Prog Neuropsychopharmacol Biol Psychiatry. 2008 Feb 15;32(2):462-6. Epub 2007 Sep 29.

PMID:
17980471
3.

Behavioral profile of a heterozygous mutant mouse model for EGF-like domain neuregulin 1.

Duffy L, Cappas E, Scimone A, Schofield PR, Karl T.

Behav Neurosci. 2008 Aug;122(4):748-59. doi: 10.1037/0735-7044.122.4.748.

PMID:
18729627
4.

Cognition in transmembrane domain neuregulin 1 mutant mice.

Duffy L, Cappas E, Lai D, Boucher AA, Karl T.

Neuroscience. 2010 Oct 27;170(3):800-7. doi: 10.1016/j.neuroscience.2010.07.042. Epub 2010 Aug 1.

PMID:
20678553
5.

Phenotypic characterization of spatial cognition and social behavior in mice with 'knockout' of the schizophrenia risk gene neuregulin 1.

O'Tuathaigh CM, Babovic D, O'Sullivan GJ, Clifford JJ, Tighe O, Croke DT, Harvey R, Waddington JL.

Neuroscience. 2007 Jun 15;147(1):18-27. Epub 2007 May 21.

PMID:
17512671
6.

Heterozygous neuregulin 1 mice display greater baseline and Delta(9)-tetrahydrocannabinol-induced c-Fos expression.

Boucher AA, Hunt GE, Karl T, Micheau J, McGregor IS, Arnold JC.

Neuroscience. 2007 Nov 23;149(4):861-70. Epub 2007 Aug 28.

PMID:
17905522
7.

Cognition in female transmembrane domain neuregulin 1 mutant mice.

Chesworth R, Downey L, Logge W, Killcross S, Karl T.

Behav Brain Res. 2012 Jan 1;226(1):218-23. doi: 10.1016/j.bbr.2011.09.019. Epub 2011 Sep 16.

PMID:
21944941
8.

Do transmembrane domain neuregulin 1 mutant mice exhibit a reliable sensorimotor gating deficit?

Karl T, Burne TH, Van den Buuse M, Chesworth R.

Behav Brain Res. 2011 Oct 1;223(2):336-41. doi: 10.1016/j.bbr.2011.04.051. Epub 2011 May 13.

PMID:
21605597
9.

The schizophrenia susceptibility gene neuregulin 1 modulates tolerance to the effects of cannabinoids.

Boucher AA, Hunt GE, Micheau J, Huang X, McGregor IS, Karl T, Arnold JC.

Int J Neuropsychopharmacol. 2011 Jun;14(5):631-43. doi: 10.1017/S146114571000091X. Epub 2010 Aug 12.

PMID:
20701826
10.

Do individually ventilated cage systems generate a problem for genetic mouse model research?

Logge W, Kingham J, Karl T.

Genes Brain Behav. 2014 Sep;13(7):713-20. doi: 10.1111/gbb.12149. Epub 2014 Jul 23.

11.

Neuregulin-1 immunoglobulin-like domain mutant mice: clozapine sensitivity and impaired latent inhibition.

Rimer M, Barrett DW, Maldonado MA, Vock VM, Gonzalez-Lima F.

Neuroreport. 2005 Feb 28;16(3):271-5.

PMID:
15706234
12.

Phenotypic effects of repeated psychosocial stress during adolescence in mice mutant for the schizophrenia risk gene neuregulin-1: a putative model of gene × environment interaction.

Desbonnet L, O'Tuathaigh C, Clarke G, O'Leary C, Petit E, Clarke N, Tighe O, Lai D, Harvey R, Cryan JF, Dinan TG, Waddington JL.

Brain Behav Immun. 2012 May;26(4):660-71. doi: 10.1016/j.bbi.2012.02.010. Epub 2012 Mar 7.

PMID:
22426432
13.

Behavioural effects of high fat diet in a mutant mouse model for the schizophrenia risk gene neuregulin 1.

Holm-Hansen S, Low JK, Zieba J, Gjedde A, Bergersen LH, Karl T.

Genes Brain Behav. 2016 Mar;15(3):295-304. doi: 10.1111/gbb.12267. Epub 2016 Feb 17.

PMID:
26707035
14.

Behavioural profile of a new mouse model for NPY deficiency.

Karl T, Duffy L, Herzog H.

Eur J Neurosci. 2008 Jul;28(1):173-80. doi: 10.1111/j.1460-9568.2008.06306.x.

PMID:
18616565
15.

Heterozygous neuregulin 1 mice are more sensitive to the behavioural effects of Delta9-tetrahydrocannabinol.

Boucher AA, Arnold JC, Duffy L, Schofield PR, Micheau J, Karl T.

Psychopharmacology (Berl). 2007 Jun;192(3):325-36. Epub 2007 Feb 28.

PMID:
17333138
16.

Parent-of-origin effects on schizophrenia-relevant behaviours of type III neuregulin 1 mutant mice.

Shang K, Talmage DA, Karl T.

Behav Brain Res. 2017 Aug 14;332:250-258. doi: 10.1016/j.bbr.2017.05.057. Epub 2017 May 31.

PMID:
28577921
17.

Distinct neurobehavioural effects of cannabidiol in transmembrane domain neuregulin 1 mutant mice.

Long LE, Chesworth R, Huang XF, Wong A, Spiro A, McGregor IS, Arnold JC, Karl T.

PLoS One. 2012;7(4):e34129. doi: 10.1371/journal.pone.0034129. Epub 2012 Apr 3.

18.

Nature vs. nurture: can enrichment rescue the behavioural phenotype of BDNF heterozygous mice?

Chourbaji S, Brandwein C, Vogt MA, Dormann C, Hellweg R, Gass P.

Behav Brain Res. 2008 Oct 10;192(2):254-8. doi: 10.1016/j.bbr.2008.04.015. Epub 2008 Apr 24.

PMID:
18538870
19.

Effect of Y1 receptor deficiency on motor activity, exploration, and anxiety.

Karl T, Burne TH, Herzog H.

Behav Brain Res. 2006 Feb 15;167(1):87-93. Epub 2005 Oct 3.

PMID:
16203045
20.

Schizophrenia-related endophenotypes in heterozygous neuregulin-1 'knockout' mice.

O'Tuathaigh CM, Harte M, O'Leary C, O'Sullivan GJ, Blau C, Lai D, Harvey RP, Tighe O, Fagan AJ, Kerskens C, Reynolds GP, Waddington JL.

Eur J Neurosci. 2010 Jan;31(2):349-58. doi: 10.1111/j.1460-9568.2009.07069.x. Epub 2010 Jan 13.

PMID:
20074216

Supplemental Content

Support Center